Xin Wei Wang, PhD
Deputy Director – Center for Cancer Research , Co-Director – Liver Cancer Program, Deputy Chief – Laboratory of Human Carcinogenesis NIH – National Cancer Institute
Seminar Title: Molecular landscape of liver cancer and its clinical implications
Host: Haitao Guo
As Deputy Director and Senior Investigator at the NCI-CCR, Dr. Wang dedicates his professional life on improving early detection, diagnosis, and treatment of liver cancer. He is also co-Director of the Multidisciplinary CCR Liver Cancer Program and Deputy Chief of the CCR Laboratory of Human Carcinogenesis, as well as members of the NIH Board of Scientific Directors. He is co-PI of the NCI-CLARITY study and the TIGER-LC consortium. Dr. Wang’s research centers on functional genomics of liver cancer utilizing genome-scale technologies paired with several international collaborative initiatives and clinical studies. His lab focuses on basic/translational research through building a global liver cancer database and employing integrated omics to understand tumor heterogeneity. He explores cutting-edge technologies such as genomics, transcriptomics, metabolomics, microbiomics, viromics and single cell analysis to define tumor subtypes, tumor cell evolution and subtype-specific biomarkers/drivers for improving early detection, diagnosis, prognosis, and prediction, and to delineate molecular mechanisms of liver cancer initiation and metastasis with applications towards precision oncology. He coauthors over 280 peer-reviewed articles (H-index 86) in top-tier journals including, Cell, Nature, Science, Cancer Cell, Nature Medicine, Nature Genetics, Gastroenterology, Hepatology, Journal of Hepatology, among others. His recent study published in Cell describes a paradigm shift approach for early detection of liver cancer. He has been an active member of AACR, AASLD, CALS, ILCA and SCBA. He was the President of CALS and SCBA DC-Chapter and council of ILCA. He received numerous awards including multiple NIH Director’s Awards, NCI Director’s Awards, and the Blue Faery Awards, among others. He serves on the editorial board of Cell & Bioscience, Hepatology, among others. He received PhD from New York University School of Medicine.
